PharmaCorp Rx Inc. (TSXV:PCRX)

Market Cap	88.78M +69.2%
Revenue (ttm)	24.08M +145.6%
Net Income	-1.62M
EPS	-0.01
Shares Out	174.08M
PE Ratio	n/a
Forward PE	25.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,500
Open	0.5350
Previous Close	0.5200
Day's Range	0.5100 - 0.5500
52-Week Range	0.4000 - 0.5500
Beta	-4.31
Analysts	Strong Buy
Price Target	0.67 (+31.37%)
Earnings Date	Aug 17, 2026

About PharmaCorp Rx

PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. The company offers prescription services; front-of-store retail, such as convenience goods, over-the-counter medications, health products, and wellness items; custom compounding; specialized consultations; and lifestyle programs. PharmaCorp Rx Inc. was incorporated in 2021 and is headquartered in Saskatoon, Canada.

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2021
• Employees: 5
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: PCRX

Financial Performance

In 2025, PharmaCorp Rx's revenue was 20.89 million, an increase of 260.57% compared to the previous year's 5.79 million. Losses were -1.48 million, 46.3% more than in 2024.

Analyst Summary

According to 3 analysts, the average rating for PCRX stock is "Strong Buy." The 12-month stock price target is $0.67, which is an increase of 31.37% from the latest price.

Price Target

$0.67

(31.37% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 21, 2026

Data Sources Report a data error